Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 316

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis

Jimenez, Sergio A., Derk, Chris T. · 2004 · Annals of Internal Medicine

Abstract

Reviews6 January 2004Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic SclerosisSergio A. Jimenez, MD and Chris T. Derk, MDSergio A. Jimenez, MDFrom Thomas Jefferson University, Philadelphia, Pennsylvania.Search for more papers by this author and Chris T. Derk, MDFrom Thomas Jefferson University, Philadelphia, Pennsylvania.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-140-1-200401060-00010 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Clinical PrinciplesSystemic sclerosis is an autoimmune connective tissue disorder of unknown cause.It is clinically heterogeneous, ranging from limited skin involvement to diffuse skin sclerosis with severe internal organ involvement.The Raynaud phenomenon, swelling of the extremities, and diffuse arthralgias often precede the onset of skin tightness and induration.Visceral involvement with fibrosis, microvascular alterations, and mononuclear cell infiltration of the gastrointestinal tract, lungs, heart, and kidneys is present to a variable extent in most patients.Autoantibodies, some with very high specificity, are present almost universally.Mortality and morbidity are substantial and are directly related to the extent of the fibrotic and microvascular alterations.A better ...References1. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al . Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202-5. [PMID: 3361530] MedlineGoogle Scholar2. Lally EV, Jimenez SA, Kaplan SR. Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients. Semin Arthritis Rheum. 1988;18:1-13. [PMID: 3187542] CrossrefMedlineGoogle Scholar3. Rodnan GP. Progressive systemic sclerosis: clinical features and pathogenesis of cutaneous involvement (scleroderma). Clin Rheum Dis. 1979;5:49-79. CrossrefGoogle Scholar4. Fritzler MJ, Kinsella TD. The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med. 1980;69:520-6. [PMID: 6968511] CrossrefMedlineGoogle Scholar5. Block JA, Sequeira W. Raynaud's phenomenon. Lancet. 2001;357:2042-8. [PMID: 11438158] CrossrefMedlineGoogle Scholar6. Pope JE. Musculoskeletal involvement in scleroderma. Rheum Dis Clin North Am. 2003;29:391-408. [PMID: 12841301] CrossrefMedlineGoogle Scholar7. Rose S, Young MA, Reynolds JC. Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am. 1998;27:563-94. [PMID: 9891698] CrossrefMedlineGoogle Scholar8. Co HT, Block JA, Sequeira W. Scleroderma lung: pathogenesis, evaluation, and current therapy. Am J Ther. 2000;7:321-4. [PMID: 11317180] CrossrefMedlineGoogle Scholar9. Coghlan JG, Mukerjee D. The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology. Curr Opin Rheumatol. 2001;13:495-9. [PMID: 11698727] CrossrefMedlineGoogle Scholar10. Deswal A, Follansbee WP. Cardiac involvement in scleroderma. Rheum Dis Clin North Am. 1996;22:841-60. [PMID: 8923599] CrossrefMedlineGoogle Scholar11. Steen VD. Scleroderma renal crisis. Rheum Dis Clin North Am. 2003;29:315-33. [PMID: 12841297] CrossrefMedlineGoogle Scholar12. Gordon MB, Klein I, Dekker A, Rodnan GP, Medsger TA. Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism. Ann Intern Med. 1981;95:431-5. [PMID: 7283293] LinkGoogle Scholar13. Lally EV, Jimenez SA. Impotence in progressively systemic sclerosis. Ann Intern Med. 1981;95:150-3. [PMID: 6789736] LinkGoogle Scholar14. Cipoletti JF, Buckingham RB, Barnes EL, Peel RL, Mahmood K, Cignetti FE, et al . Sjogren's syndrome in progressive systemic sclerosis. Ann Intern Med. 1977;87:535-41. [PMID: 921080] LinkGoogle Scholar15. Fleischmajer R, Perlish JS, Reeves JR. Cellular infiltrates in scleroderma skin. Arthritis Rheum. 1977;20:975-84. [PMID: 861067] CrossrefMedlineGoogle Scholar16. Jimenez SA. Cellular immune dysfunction and the pathogenesis of scleroderma. Semin Arthritis Rheum. 1983;13:104-13. [PMID: 6353581] CrossrefMedlineGoogle Scholar17. Feghali-Bostwick C, Medsger TA, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 2003;48:1956-63. [PMID: 12847690] CrossrefMedlineGoogle Scholar18. Jimenez SA, Diaz A, Khalili K. Retroviruses and the pathogenesis of systemic sclerosis. Int Rev Immunol. 1995;12:159-75. [PMID: 7650419] CrossrefMedlineGoogle Scholar19. Dang H, Dauphinee MJ, Talal N, Garry RF, Seibold JR, Medsger TA, et al . Serum antibody to retroviral gag proteins in systemic sclerosis. Arthritis Rheum. 1991;34:1336-7. [PMID: 1930323] CrossrefMedlineGoogle Scholar20. Pandey JP, LeRoy EC. Human cytomegalovirus and the vasculopathies of autoimmune diseases (espec

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-140-1-200401060-00010

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 49 references

Cited by

See all 316

Metadata

Authors
Jimenez, S. A., & Derk, C. T.
Venue
Annals of Internal Medicine
Published
2004-01-06
Volume
140
Issue
1
Pages
37-50
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2112162481
Cited by
316
References
49
FWCI
15.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis. https://app.cochat.ai/papers/10.7326/0003-4819-140-1-200401060-00010
The paper
Jimenez, S. A., & Derk, C. T. (2004). Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-140-1-200401060-00010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.